Strides Arcolab said on Friday its fully owned unit Onco Therapies Ltd has received European Union approval for its oncology drug carboplatin.
The drug has annual sales of $138 million in Europe,it said in a statement.
Carboplatin is the first approved product from the 22 filings made by Onco Therapies,it said adding the product would be manufactured in Bangalore.